Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remel is a prominent brand and manufacturer in the field of microbiology, specializing in the production of high-quality culture media, diagnostic tests, and laboratory reagents. Founded in 1971 and currently operating as part of Thermo Fisher Scientific, the company provides essential tools for clinical, industrial, and research laboratories worldwide. Its product portfolio includes prepared and dehydrated culture media, antimicrobial susceptibility testing (AST) systems, and rapid identification kits for various pathogens. Remel's solutions are critical for the detection and characterization of microorganisms in healthcare and food safety settings. The company is headquartered in Lenexa, Kansas, where it maintains significant manufacturing and distribution operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remel.